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Abstract The aquaporin channel family was first considered as a family of water
channels, however it is now clear that some of these channels are also permeable to
small solutes such glycerol, urea and monocarboxylates. In this review, we will
consider AQP4 and AQP9 expressed in the rodent brain. AQP4 is present on
astrocytic end-feet in contact with brain vessels and could be involved in ionic
homeostasis. However, AQP4 may also be involved in cell adhesion. AQP4
expression is highly modified in several brain disorders and it can play a key role in
the cerebral edema formation. However, the exact role of AQP4 in edema formation
is still debated. Recently, AQP4 has been shown to be also involved in astrocyte
migration during glial scar formation. AQP9 is expressed in astrocytes and in
catecholaminergic neurons. Two isoforms of AQP9 are expressed in brain cells, the
shortest isoform is localized in the inner membrane of mitochondria and the longest
in the cell membrane. The level of expression of AQP9 is negatively regulated by
high concentrations of insulin. Taken together, these results suggest that AQP9 could
be involved in brain energy metabolism. The induction of AQP9 in astrocytes is
observed with time after stroke onset suggesting participation in the clearance of
excess lactate in the extracellular space. These recent exciting results suggest that
AQPs may not only be involved in water homeostasis in the brain but could also
participate in other important physiological functions.
Keywords Water channel . Glycerol . Lactate . Catecholaminergic neurons .
Edema . Ischemia
Water is an important molecule involved in several biochemical processes present in
living cells. Water was considered for a long time to freely diffuse through the
plasma membrane, but this hypothesis was revisited after the discovery of water
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channels (Preston et al. 1992). The water channel family is still growing with 13
members ubiquitously distributed in mammalian tissues. The importance of these
channels for life is supported by the fact that there are more than 150 types of AQPs
in microbes, invertebrates, non mammalian vertebrates and plants (Santoni et al. 2000).
These channels have been highly conserved throughout evolution and the family
is now divided accordingly to sequence homology and permeability into aquaporins
and aquaglyceroporins.
Research in this field has significantly advanced in the last years, and in this
review we will illustrate several new potential functional roles for brain AQPs.
Water channels: a general introduction
Aquaporins (AQP) are water channel proteins with a molecular weight of around
30 kDa, and exhibit a common structure of six membrane spanning alpha helical
domains with intracellular carboxyl (C) and amino (N) termini. They contain a
consensus motif Asn-Pro-Ala (NPA), implied in pore formation (Badaut et al. 2002).
As mentioned above, the AQP family is now divided into two subgroups based on
sequence homology (Amiry-Moghaddam and Ottersen 2003): aquaporin and
aquaglyceroporin.
The subgroup aquaporin is composed of AQP0, 1, 2, 4, 5, 6, 8 and is considered
to be mainly permeable to water with a high flow rate. A few of these pure water
channels are also permeable to anion (AQP6) and volatile solutes such as CO2 for
AQP1 (Cooper et al. 2002). Water diffusion through AQPs is inhibited by mercury,
except AQP4 which is a mercury-insensitive aquaporin (Amiry-Moghaddam and
Ottersen 2003).
The second subgroup aquaglyceroporins, is composed of AQP3, 7, 9, 10 and
bacterial glycerol facilitator (Glpf; Badaut and Regli 2004). These channels are
permeable to water and glycerol. AQP9, a member of this group, was also surnamed
“neutral channel” (Tsukaguchi et al. 1998). Indeed, the presence of AQP9 in
Xenopus Oocytes or proteoliposomes injected facilitates the diffusion of water, but
also polyols (glycerol, mannitol, and sorbitol), purines (adenine), pyrimidines (uracil
and chemotherapeutic agent 5-fluorouracil) and monocarboxylates (lactate and β-
hydroxybutyrate; Ishibashi et al. 1998; Tsukaguchi et al. 1998; Ko et al. 1999;
Tsukaguchi et al. 1999; Carbrey et al. 2003). However, the osmotic water coefficient
for AQP9 is lower than in a pure water channel like AQP4 (Carbrey et al. 2003). In
addition, AQP9 facilitates metalloid transport further suggesting that APQ9 may be a
major route of arsenite uptake into mammalian cells (Liu et al. 2002).
Water homeostasis is critical to sustain normal neural activity. An increase in the
water content into the brain leads to brain swelling and rapidly becomes deleterious.
Obviously, the knowledge of the distribution and regulation of water channels in the
brain is important to understand water homeostasis. To date, six aquaporin subtypes
(AQP1, AQP3, AQP4, AQP5, AQP8, AQP9 have been described in rodent brain
cells. However, only three aquaporins have been clearly identified in brain cells in
vivo: AQP1, AQP4 and AQP9 (Badaut et al. 2002). AQP1 is expressed in epithelial
cells of the choroid plexus (Nielsen et al. 1993), and is proposed to be involved in
cerebrospinal fluid formation (Brown et al. 2004). Expression of AQP1 is seen in
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many non-brain endothelia (Nielsen et al. 1993) but its expression is suppressed in
the specialized endothelial cells of the blood–brain barrier (Dolman et al. 2005).
Indeed, the presence of astrocytes inhibits the expression of AQP1 in endothelial
cells (Dolman et al. 2005). In this review, we will focus on distributions and putative
roles of AQP4 and 9 in the mammalian brain. Recent reports concerning the level of
expression of AQP in brain disorders will be then presented.
AQP4 expression in brain and its several functional roles
Historically, mRNA for AQP4 was first observed by in situ hybridization in the rat
brain, with expression of the messenger in the glia limitans, the ependymal lining
system, the magnocellular hypothalamic nuclei, the cerebellum, the hippocampus,
the neocortex and in the medial habenular nucleus (Jung et al. 1994; Venero et al.
1999). This regional distribution for AQP4 mRNA was confirmed by several
immunohistochemistry studies (Nielsen et al. 1997; Badaut et al. 2000a, b). AQP4
protein is present on astrocyte endfeet in contact with blood vessels but also on
astrocytic processes in contact with the synapses (Nielsen et al. 1997; Badaut et al.
2000a, b).
Electronic microscopy studies after cryofracture and immunogold techniques
have shown that the highest density of AQP4 in astrocyte endfeet was observed in
geometric structures named orthogonal arrays of proteins (OAPs; Verbavatz et al.
1997; Rash et al. 1998, 2004). Interestingly, the ratio between the expression of the
long and the short AQP4 splice variant (AQP4m1 and AQP4m23) determines the
size of the OAPs (Rash et al. 2004). The AQP4m23 isoform stabilizes the structure
of the OAPs and an increase of its expression induces an increase in the size of the
OAPs (Rash et al. 2004). The first functional role of the OAPs has been suggested to
be an involvement with the astrocytic potassium-buffering (Grange-Messent et al.
1996). To date, functional consequences of the variation of the size of the OAPs are
not known. Recently, another physiological role has been suggested for AQP4, in
cell adhesion (Hiroaki et al. 2006). The involvement of an APQ in cell adhesion has
been well described for epithelial cells of the lens, where AQP0 participates in the
linkage of cells (Gonen et al. 2004). The high level of AQP4 protein in the
hypothalamic glia lamellae should facilitate the adhesion between the astrocyte
processes (Hiroaki et al. 2006). In this situation, AQP4 should not be involved in
water diffusion but rather in cell adhesion between astrocytes and possibly to
endothelial cells or muscle cells in the perivascular compartment. To support this
idea, recent reports showed that the presence of AQP4 of the endfoot membrane is
dependent on the presence of proteins in the basal lamina such as agrin, α-
dystroglycan and laminin (Guadagno and Moukhles 2004; Warth et al. 2004),
suggesting an involvement in the ability of astrocytes to maintain the integrity of the
blood–brain barrier. In the intracellular region, AQP4 is anchored to several proteins
of the astrocytic cytoskeleton such as α1-syntrophin and dystrophin (Frigeri et al.
2001; Neely et al. 2001; Vajda et al. 2002; Amiry-Moghaddam et al. 2004).
However, AQP4 is also observed outside the OAPs (Warth et al. 2004) raising the
following questions: is there a water diffusion inside the OAPs? Is there a difference
in the capacity of water diffusion inside or outside the OAPs? These questions are
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crucial because induction of AQP4 has been described in several brain diseases such
as ischemia (Badaut et al. 2002).
Some new insights were obtained from two mice strains deficient in gene
expression of dystrophin (mdx) and α1-syntrophin (a protein linked to dystrophin)
which exhibit a marked decrease in AQP4 immunolabeling with swelling of
astrocytic end-feet (Frigeri et al. 2001; Neely et al. 2001; Vajda et al. 2002; Amiry-
Moghaddam et al. 2004). In mdx and syntrophin knock out mice, astrocyte swelling
may be due to impaired water elimination resulting from AQP4-disturbed
organization at the plasma membrane. Another clue to the function of perivascular
AQP4 was obtained by platelet-derived growth factor B (PDGF-B)-knockout mice,
which showed abnormal vascular morphogenesis resulting in the absence of
pericytes, and the presence of endothelial hyperplasia already at embryonic
day 11.5 (Hellstrom et al. 2001). These knockout mice showed an increase in
AQP4 concentration and swelling of astrocytes which may be a response to vascular
abnormalities (Hellstrom et al. 2001). Similarly, a significant induction of AQP4
expression was observed on astrocyte endfeet in the ischemic hemisphere, one hour
after stroke onset (de Castro Ribeiro et al. 2006). These results suggest that the
increased AQP4 content of the perivascular space highlights the need for rapid
water movements in this region. The pattern of distribution of aquaporins within
the perivascular space might be related to the control of the perivascular volume,
a function that may be crucial for maintenance of cerebral blood perfusion
(Badaut et al. 2000b) and facilitation of the water clearance from perivascular
space.
In the rodent brain, several regions show a strong AQP4 immunoreactive signal
that may be due to the presence of the channel outside the perivascular space on
astrocyte processes surrounding neuronal cells (Nielsen et al. 1997; Venero et al.
1999; Badaut et al. 2000b). The cellular distribution of AQP4 protein suggest that it
may be involved in potassium homeostasis due to its co-distribution with KIR4.1
(Nagelhus et al. 2004). This hypothesis is also supported by functional results
obtained from AQP4 KO mice showing that the delay of potassium re-uptake during
electrical activity is increased and therefore these mice develop seizures more easily
(Binder et al. 2006). The perivascular pool of AQP4 anchored by α-syntrophin,
seems to have an important role in this spatial potassium buffering because the delay
of potassium re-uptake during electrical activity is also increased in α-syntrophin
KO mice (Amiry-Moghaddam et al. 2003b). Interestingly, observations in sclerotic
tissues from patients with mesial temporal lobe epilepsy and hippocamplal sclerosis,
suggest that the loss of perivascular AQP4 could be secondary due to the absence of
brain specific dystrophin in these pathological tissues (Eid et al. 2005). This
hypothesis suggests that the clearance of extracellular potassium can be compro-
mised which then contributes to the accumulation of extracellular potassium in the
brain of these patients. These results support the concept that AQP4 plays an
important role in ionic homeostasis by facilitating water diffusion.
Potassium spatial buffering is facilitated by application of vasopressin (VP), an
anti-diuretic hormone, which stimulates V1b receptors in acute cortical slices
(Niermann et al. 2001). The increase in extracellular potassium clearance after VP
application may be due an increase of AQP4 expression (Niermann et al. 2001). In
contrast to brain, the effect of VP on the level of AQP4 and AQP2 expression is well
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described in the kidney (King et al. 2000). However, direct regulation of the level of
AQP4 expression by VP has never been demonstrated in the central nervous system.
VP is synthesized in the magnocellular and parvocellular neurons of the
hypothalamic nuclei, paraventricular and supraoptic nuclei and released into the
blood stream in the neurohypophysis. These hypothalamic nuclei are known to be
involved in the central osmoreception of variations of plasma osmotic pressure
(Wells 1998). The high level of AQP4 and similar distribution have been observed in
all osmosensitive brain areas such as the subfornical organ, the supraoptic nuclei, the
paraventricular nucleus and accessory nuclei such as the circularis nucleus (Nielsen
et al. 1997; Badaut et al. 2000a). In these brain regions, AQP4 is on plasma
membranes facing both capillaries and magnocellular neurons (Nielsen et al. 1997;
Badaut et al. 2000a). The specificity and intensity of AQP4 staining within
hypothalamic magnocellular nuclei strongly suggest that water channels allow
variations of plasma osmotic pressure to be transferred from blood to osmosensitive
neurons. Furthermore, high blood vessel density is another common feature of these
nuclei, which contribute to plasma osmolarity detection (Badaut et al. 2000a).
AQP9 expression in brain and its functional roles
Aquaglyceroporins facilitate the diffusion of water and several solutes such as
glycerol, urea and monocarboxylate. The highest level of expression of AQP9 is in
the liver (Tsukaguchi et al. 1998; Elkjaer et al. 2000) with polarization of the protein
to the hepatocytic plasma membrane facing the sinusoids (Elkjaer et al. 2000;
Nicchia et al. 2001; Nihei et al. 2001). The expression of AQP9 is also observed in
the rodent brain (Badaut and Regli 2004). AQP9 mRNA was first detected in
astrocytic cultures (Tsukaguchi et al. 1998) and confirmed by immunocytochemical
studies in rodent brain (Badaut et al. 2001, 2004). To date, AQP9 expression has
been observed in three cell types: glial cells, in particular tanycytes and astrocytes
(Elkjaer et al. 2000; Badaut et al. 2001, 2004), endothelial cells of sub-pial vessels
(Badaut et al. 2004) and neurons (Badaut et al. 2004; de Castro Ribeiro et al. 2006).
AQP9 expression was found predominantly in one subtype of neuronal cells, the
catecholaminergic neurons, characterized by tyrosine hydroxylase expression in rat
and mouse brains (Badaut et al. 2004; de Castro Ribeiro et al. 2006). In agreement
with the regional distribution of AQP9 protein by immunohistochemistry, high levels
of mRNA for AQP9 was detected in catecholaminergic nuclei confirming the
presence of this protein in these nuclei (Badaut et al. 2004). Regarding these results,
a sole role for AQP9 in water homeostasis should be revised, as to the best of our
knowledge, catecholaminergic neurons are not directly implied in the regulation of
systemic osmotic pressure, but are rather involved in energy balance (Grill and
Kaplan 2002; Penicaud et al. 2002). This leads us to postulate that AQP9 could be
involved in brain energy metabolism as a metabolite channel. In agreement with this
hypothesis, the presence of AQP9 protein was recently demonstrated in mitochon-
dria of astrocytes and dopaminergic neurons (Amiry-Moghaddam et al. 2005).
Indeed, two isoforms of AQP9 are expressed in brain cells. The shortest isoform of
AQP9 (26 kDa) is observed in inner membrane of the mitochondria and the longest
isoform (30 kDa) is present in cell membrane (Amiry-Moghaddam et al. 2005). It is
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possible that the presence of AQP9 facilitates the diffusion of glycerol and
monocarboxylates, which serve as energy substrates for neurons (McKenna et al.
1986; Magistretti et al. 1999; Nguyen et al. 2003). Interestingly, utilization of
glycerol by neuronal cells in vitro was inhibited by mercury, suggesting transport by
an AQP (Nguyen et al. 2003). In the “lactate shuttle” model, glucose is transformed
by astrocytes into lactate and diffuses from astrocytes to neurons using the
monocarboxylate transporters (Magistretti and Pellerin 1999). Therefore, presence
of AQP9 in astrocytes suggests that it may facilitate the diffusion of lactate to
neuronal cells in conjunction with the monocarboxylate transporters.
In addition, some catecholaminergic neurons are known to be sensitive to
variations in glucose levels and recently, lactate and glycerol have been also shown
to be potential activators of these neurons (Yang et al. 1999; Ainscow et al. 2002;
Penicaud et al. 2002). These neurons are located in the same brain areas as AQP9-
positive neurons (Badaut and Regli 2004). Taken together, these results raise the
hypothesis that neuronal AQP9 plays a role in energy balance as a glycerol-lactate-
channel, but this awaits functional proof.
In liver, AQP9 expression has been shown to be regulated by the physiological
feeding state mediated by the insulin response element (IRE) in the promoter of the
gene (Kuriyama et al. 2002). High plasma insulin suppresses glycerol uptake into
hepatocytes which participates in neoglucogenosis to replenish blood glucose
concentrations. AQP9 is down regulated by high insulin concentration suggesting
that AQP9 may play a key role in cellular energy balance as a glycerol channel in the
liver (Kuriyama et al. 2002; Carbrey et al. 2003). In vivo, the expression of AQP9 is
increased after fasting and returns to basal levels upon refeeding (Carbrey et al.
2003). AQP9 expression in liver is dramatically increased in models of diabetes
induced by streptozotocin (STZ) injection (Carbrey et al. 2003) and in a mouse
model of insulin resistance (Kuriyama et al. 2002). As mentioned above, energy
balance is regulated by detection of glucose levels in the periphery as well as in the
central nervous system (Levin et al. 1999). The feeding state, set by blood insulin
concentration, also influences the glucose sensitive areas of the brain. Interestingly,
AQP9-positive neurons are present in brain regions known to be glucose sensitive or
implicated in the feeding state (Badaut et al. 2004); systemic insulin has been
reported to cross the BBB, and insulin receptors are expressed in catecholaminergic
neurons (Kyriaki 2003; Unger et al. 1991 #211). These data lead us to investigate
whether brain AQP9 expression is regulated by insulin. The first in vitro results on
brain stem slices containing catecholaminergic neurons showed a decrease in AQP9
protein levels 6 h after insulin application (Badaut et al. 2005). In vivo, the level of
AQP9 was increased in liver and in the NTS of rats treated with STZ injections to
induce diabetes (Badaut and Regli 2004; Badaut et al. 2005). Therefore, it would
appear that brain AQP9 expression appears is regulated by insulin concentrations,
supporting the hypothesis that AQP9 is involved in brain energy metabolism.
AQP9 was also observed in endothelial cells of the pial vessels, and in the
intraparenchymal vessels (Badaut et al. 2004; Amiry-Moghaddam et al. 2005).
interestingly in mice, AQP4 expression was observed by immunogold labeling in
endothelial cells at their luminal, as well as abluminal membranes, but at much lower
levels than observed on astrocytic endfeet (Amiry-Moghaddam et al. 2004). The
blood–brain barrier (BBB) is known to be highly permeable to water (Oldendorf
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1970) and therefore, AQP4 and AQP9 may facilitate the water flow through
endothelial cells. AQP9 could also participate in diffusion of monocarboxylate
through the BBB which is mainly carried out by the monocarboxylate transporter,
MCT1, highly expressed in endothelial cells (Gerhart et al. 1997; Pierre et al. 2000;
Bergersen et al. 2002).
AQP expression in brain disorders
As mentioned previously, AQPs in rodent brain as water-channels are likely to play
an important role in extracellular homeostasis, and thus may sustain normal neuronal
activity (Badaut et al. 2002). A profound perturbation of the brain environment
usually induces a regional cerebral edema, as observed in ischemia. Brain edema
which leads to an expansion of brain volume, has a crucial impact on morbidity and
mortality after stroke as it increases intracranial pressure, favours herniations, and
contributes to additional ischemic injuries (Klatzo 1985). Despite its complexity,
brain oedema has been defined as an increase in net brain water content which leads
to an increase in tissue volume (Pappius 1974). The two major types of brain
oedema, cytotoxic and vasogenic oedema, both occur after brain ischemia. Cytotoxic
oedema is characterized by intracellular water accumulation involving both
astrocytes and neurons and depending mainly on the perturbation of ionic gradients
(Kimelberg 2004). Vasogenic oedema is characterized by a protein rich exudate
derived from plasma, as a result of an increased permeability of the capillary
endothelial cells to albumin and other plasma proteins (Unterberg et al. 2004).
As mentioned previously, three AQPs could be involved in water movements
occurring during formation and resolution of cerebral edema after ischemia.
Astrocytic AQP1 expression is induced in human brain tissues after subarachnoid
hemorrhage (SAH; Badaut et al. 2003) but modification in expression has not yet
been described in rodent models of human brain disorders (de Castro Ribeiro et al.
2006). The level of AQP4 expression is regulated in several brain disorders, such as
trauma (Ke et al. 2001; Kiening et al. 2002; Sun et al. 2003), ischemia (Taniguchi et
al. 2000; Amiry-Moghaddam et al. 2003a; Meng et al. 2004; de Castro Ribeiro et al.
2006) and human SAH (Badaut et al. 2003). To better understand the roles of AQP4
and AQP9 in edema, the expression profiles were recently characterized at various
time points after transient cerebral ischemia in mice. Two peaks of AQP4 expression
were observed 1 h and 48 h after stroke, coinciding with the two peaks of maximal
hemispheric swelling (de Castro Ribeiro et al. 2006). This temporal expression of
AQP4 differs with the result from brain trauma where there is an initial decrease in
AQP4 levels within 48 hours, followed by an increase (Ke et al. 2001, 2002;
Kiening et al. 2002). The difference in expression between the two models suggests
that the role of AQP4 in edema formation and resolution is complex. In contrast to
AQP4, AQP9 showed a significant induction at 24 h, that increased gradually with
time, without correlation to swelling (de Castro Ribeiro et al. 2006), suggesting that
AQP4 but not AQP9 plays a role in edema formation after transient cerebral
ischemia in the mouse. Interestingly, AQP4 expression is rapidly regulated with a
major induction at 1 h after stroke onset on astrocyte endfeet, suggesting that we
need to consider early time points after brain disorder onset (de Castro Ribeiro et al.
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2006). To date, functional consequences of the early AQP4 induction on astrocyte
endfeet have not yet been determined. It is possible that the presence of AQP4 in
cytotoxic edema formation is deleterious (Manley et al. 2000). Indeed, edema is
lower in AQP4-KO mice compared to wild type after permanent ischemia and acute
water intoxication (Manley et al. 2000). On the other hand, AQP4 was shown to be
important in water clearance in vasogenic edema (Papadopoulos et al. 2004).
Perhaps, AQP4 plays a dual role in edema evolution. However, a treatment with
sulforaphane which enhances AQP4 expression, induces a decrease in edema
following traumatic brain injury (Zhao et al. 2005), suggesting that induction of
AQP4 expression could facilitate the water clearance to decrease edema.
As mentioned previously, the role of AQP4 in brain disorders is complex. Indeed,
AQP4 has been recently shown to be involved in glial scar formation due to its
involvement in astrocyte migration towards the lesion (Saadoun et al. 2005). This
new role for AQP4 illustrates well that one AQP could be involved in several
cellular functions in one organ and in one cell type, depending on the environment.
AQP9 protein is up-regulated on reactive astrocytes in the border of the infarct after
transient middle cerebral artery occlusion in mice (Badaut et al. 2001; de Castro
Ribeiro et al. 2006). This up-regulation of AQP9 in reactive astrocytes was also
observed in the border zone not influenced by the middle cerebral artery territory (de
Castro Ribeiro et al. 2006). AQP9 permeability to water, glycerol and lactate may be
important under pathological conditions such as brain ischemia (Bertrand et al. 1992;
Schulz et al. 2000; Frykholm et al. 2001; Kuo et al. 2003) and interestingly, AQP9
permeability to lactate increases fourfold when the pH decreases to 5.5 (Tsukaguchi
et al. 1998). Lactic acidosis during ischemia may increase the permeability of AQP9
and enable uptake of excess lactate by astrocytes. In this way AQP9 could favor
lactate and glycerol clearing from the extracellular space during ischemia. Lactate and
glycerol could then be used as energetic substrates, lactate, for example, has been
shown to facilitate the recovery of neurons after ischemic insults (Schurr 2002).
To date, molecular pathways involved in AQP4 and 9 regulation have not yet
been studied in vivo. However several groups have investigated the regulation of
AQP expression in primary astrocyte cultures. Several pathways leading to
regulation of AQP expression were identified including protein kinase A (PKA)
and C (PKC; Yamamoto et al. 2001, 2002). Stimulation of the PKC pathway is
known to reduce AQP4 mRNA expression in astrocyte cultures (Nakahama et al.
1999) and furthermore, PKC phosphorylation at consensus sites in the AQP4 protein
acts to reduce water influx through the channel (Han et al. 1998; Vajda et al. 2000).
AQP9 mRNA and protein were also down-regulated by stimulation of the PKC
pathway which did not require de novo protein synthesis (Yamamoto et al. 2001).
Despite the presence of consensus sites for phosphorylation by PKC in the AQP9
protein, direct regulation of this channel by phosphorylation has not yet been
observed (Yamamoto et al. 2001). Activation of PKA by dibutirylcAMP induces an
increase in AQP9 mRNA and protein expression in contrast to AQP4 in astrocytic
cultures (Yamamoto et al. 2002). Recently, P38 MAP-kinase was shown to be
involved in an increase of AQP4 and AQP9 expression after osmotic stress (Arima
et al. 2003). MAP-kinase pathways is activated in ischemia and then could be also
involved in the increase of astrocytic AQP9 expression at the border of the ischemic
infarct (Badaut et al. 2001; de Castro Ribeiro et al. 2006).
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Conclusion
Regarding to recent advances, a unique role of AQP in brain water homeostasis
needs to be reconsidered. AQP4 is involved in ionic homeostasis of the brain by
facilitation of water diffusion through the cell membrane. An absence of AQP4 in
astrocyte endfeet modifies the clearance of potassium during neuronal activity and
leads to an increase in the susceptibility of animals to seizure. In pathological
conditions, expression of AQP4 is rapidly increased and correlated with edema
formation. However, the exact role of AQP4 in edema formation is still debated.
Furthermore, the induction of AQP4 in reactive astrocytes after traumatic brain
injury has been recently associated with astrocyte migrations towards the glia scar.
AQP9 is expressed in astrocytes and catecholaminergic neurons and may be
involved in brain energy metabolism by facilitating the diffusion of solutes such as
glycerol and monocarboxylates. Furthermore, the level of AQP9 expression is
dependent on the concentration of insulin, supporting the idea that AQP9 is involved
in brain energy metabolism. In ischemia, the AQP9 expression is induced over time
and could participate in the reuptake of excess glycerol and lactate after stroke onset.
Recent reports on AQP9 suggest that the AQP is not only an aqueduct but a
metabolite pipeline.
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